Vistagen Therapeutics (VTGN) News
NASDAQ: VTGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
VTGN news summary
We found 4 recent headlines mentioning Vistagen Therapeutics (VTGN): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. VTGN is making an outsized move today, down 12.33% at $0.1636, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update", was published by GlobeNewswire on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Vistagen Therapeutics headlines
- Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate UpdateAdvancing potential to execute Phase 3 development plan for fasedienol in social anxiety disorder following constructive FDA feedback, with disciplined capital management and strategic flexibility…GlobeNewswire
- Vistagen Therapeutics, Inc. Announces Regulatory Update Following Type C Meeting with FDA on Phase 3 Development of FasedienolOn November 9, 2026, Vistagen Therapeutics, Inc. announced a regulatory update from its recent, productive Type C meeting with the U.S. Food and Drug Administration to discuss potential…NasdaqVTGN, BRK.B
- Vistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety DisorderConstructive feedback from FDA clarifies potential Phase 3 development path forward Constructive feedback from FDA clarifies potential Phase 3 development path forwardGlobeNewswire
- Vistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development ProgramsCollaboration combines Vistagen’s neuroscience expertise and datasets with GATC Health’s predictive modeling capabilities to provide additional insights for protocol development and resource…GlobeNewswire